Hollow gold nanoparticles as biocompatible radiosensitizer: An in vitro proof of concept study

Chienwen Huang, Vasant Kearney, Sina Moeendarbari, Ruiqian Jiang, Preston Christensen, Rakesh Tekade, Xiankai Sun, Weihua Mao, Yaowu Hao

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

We report in vitro studies on radiotherapy enhancement of hollow gold nanoparticles (HAuNPs), which feature a 50 nm hollow core and a 30 nm thick polycrystalline shell. A clonogenic cell survival assay was used to assess radiation dose enhancement on breast cancer MDA-MB-231 cells. Cells were cultured in a cell culture solution in which pegylated HAuNPs were added. No cytotoxicity of the HAuNPs was observed at the nanoparticle concentration up to 4.25×10<sup>9</sup> nanoparticles/ml (350 μM Au concentration). A small animal X-ray irradiator and a clinical linear accelerator were used to irradiate HAuNP-treated and control groups. It shows that the radiation damage to the cells is significantly enhanced when the cells are exposed to HAuNPs. This is the first time that AuNPs with diameter larger than 100 nm has been studied for their radiosensitizing effects. In clinical settings, we envision that HAuNPs could be intratumorally injected into tumors, which is more realistic for practical usage of AuNPs as radiosensitizer than passive accumulation in tumors using the enhanced permeability and retention effect or active targeting. Larger particles are favored for the intratumoral injection approach since larger particles tend to be retained in the injection sites, and are less likely to diffuse into surrounding normal tissues. So, this proof-of-concept evaluation shows a promising potential to use HAuNPs as radiation therapy sensitizer for cancers.

Original languageEnglish (US)
Pages (from-to)106-112
Number of pages7
JournalJournal of Nano Research
Volume32
DOIs
StatePublished - 2015

Fingerprint

Gold
hollow
Radiotherapy
gold
Nanoparticles
nanoparticles
Tumors
radiation therapy
tumors
cancer
cells
injection
Radiation-Sensitizing Agents
multiple docking adapters
Linear accelerators
augmentation
Radiation damage
linear accelerators
Cytotoxicity
radiation damage

Keywords

  • Gold nanoparticles
  • Hollow nanoparticles
  • Radiation dose enhancement
  • Radiation therapy

ASJC Scopus subject areas

  • Materials Science(all)
  • Physics and Astronomy(all)

Cite this

Huang, C., Kearney, V., Moeendarbari, S., Jiang, R., Christensen, P., Tekade, R., ... Hao, Y. (2015). Hollow gold nanoparticles as biocompatible radiosensitizer: An in vitro proof of concept study. Journal of Nano Research, 32, 106-112. https://doi.org/10.4028/www.scientific.net/JNanoR.32.106

Hollow gold nanoparticles as biocompatible radiosensitizer : An in vitro proof of concept study. / Huang, Chienwen; Kearney, Vasant; Moeendarbari, Sina; Jiang, Ruiqian; Christensen, Preston; Tekade, Rakesh; Sun, Xiankai; Mao, Weihua; Hao, Yaowu.

In: Journal of Nano Research, Vol. 32, 2015, p. 106-112.

Research output: Contribution to journalArticle

Huang, C, Kearney, V, Moeendarbari, S, Jiang, R, Christensen, P, Tekade, R, Sun, X, Mao, W & Hao, Y 2015, 'Hollow gold nanoparticles as biocompatible radiosensitizer: An in vitro proof of concept study', Journal of Nano Research, vol. 32, pp. 106-112. https://doi.org/10.4028/www.scientific.net/JNanoR.32.106
Huang, Chienwen ; Kearney, Vasant ; Moeendarbari, Sina ; Jiang, Ruiqian ; Christensen, Preston ; Tekade, Rakesh ; Sun, Xiankai ; Mao, Weihua ; Hao, Yaowu. / Hollow gold nanoparticles as biocompatible radiosensitizer : An in vitro proof of concept study. In: Journal of Nano Research. 2015 ; Vol. 32. pp. 106-112.
@article{fe19189b500a4daaa2927c8209acb4a5,
title = "Hollow gold nanoparticles as biocompatible radiosensitizer: An in vitro proof of concept study",
abstract = "We report in vitro studies on radiotherapy enhancement of hollow gold nanoparticles (HAuNPs), which feature a 50 nm hollow core and a 30 nm thick polycrystalline shell. A clonogenic cell survival assay was used to assess radiation dose enhancement on breast cancer MDA-MB-231 cells. Cells were cultured in a cell culture solution in which pegylated HAuNPs were added. No cytotoxicity of the HAuNPs was observed at the nanoparticle concentration up to 4.25×109 nanoparticles/ml (350 μM Au concentration). A small animal X-ray irradiator and a clinical linear accelerator were used to irradiate HAuNP-treated and control groups. It shows that the radiation damage to the cells is significantly enhanced when the cells are exposed to HAuNPs. This is the first time that AuNPs with diameter larger than 100 nm has been studied for their radiosensitizing effects. In clinical settings, we envision that HAuNPs could be intratumorally injected into tumors, which is more realistic for practical usage of AuNPs as radiosensitizer than passive accumulation in tumors using the enhanced permeability and retention effect or active targeting. Larger particles are favored for the intratumoral injection approach since larger particles tend to be retained in the injection sites, and are less likely to diffuse into surrounding normal tissues. So, this proof-of-concept evaluation shows a promising potential to use HAuNPs as radiation therapy sensitizer for cancers.",
keywords = "Gold nanoparticles, Hollow nanoparticles, Radiation dose enhancement, Radiation therapy",
author = "Chienwen Huang and Vasant Kearney and Sina Moeendarbari and Ruiqian Jiang and Preston Christensen and Rakesh Tekade and Xiankai Sun and Weihua Mao and Yaowu Hao",
year = "2015",
doi = "10.4028/www.scientific.net/JNanoR.32.106",
language = "English (US)",
volume = "32",
pages = "106--112",
journal = "Journal of Nano Research",
issn = "1662-5250",
publisher = "Trans Tech Publications",

}

TY - JOUR

T1 - Hollow gold nanoparticles as biocompatible radiosensitizer

T2 - An in vitro proof of concept study

AU - Huang, Chienwen

AU - Kearney, Vasant

AU - Moeendarbari, Sina

AU - Jiang, Ruiqian

AU - Christensen, Preston

AU - Tekade, Rakesh

AU - Sun, Xiankai

AU - Mao, Weihua

AU - Hao, Yaowu

PY - 2015

Y1 - 2015

N2 - We report in vitro studies on radiotherapy enhancement of hollow gold nanoparticles (HAuNPs), which feature a 50 nm hollow core and a 30 nm thick polycrystalline shell. A clonogenic cell survival assay was used to assess radiation dose enhancement on breast cancer MDA-MB-231 cells. Cells were cultured in a cell culture solution in which pegylated HAuNPs were added. No cytotoxicity of the HAuNPs was observed at the nanoparticle concentration up to 4.25×109 nanoparticles/ml (350 μM Au concentration). A small animal X-ray irradiator and a clinical linear accelerator were used to irradiate HAuNP-treated and control groups. It shows that the radiation damage to the cells is significantly enhanced when the cells are exposed to HAuNPs. This is the first time that AuNPs with diameter larger than 100 nm has been studied for their radiosensitizing effects. In clinical settings, we envision that HAuNPs could be intratumorally injected into tumors, which is more realistic for practical usage of AuNPs as radiosensitizer than passive accumulation in tumors using the enhanced permeability and retention effect or active targeting. Larger particles are favored for the intratumoral injection approach since larger particles tend to be retained in the injection sites, and are less likely to diffuse into surrounding normal tissues. So, this proof-of-concept evaluation shows a promising potential to use HAuNPs as radiation therapy sensitizer for cancers.

AB - We report in vitro studies on radiotherapy enhancement of hollow gold nanoparticles (HAuNPs), which feature a 50 nm hollow core and a 30 nm thick polycrystalline shell. A clonogenic cell survival assay was used to assess radiation dose enhancement on breast cancer MDA-MB-231 cells. Cells were cultured in a cell culture solution in which pegylated HAuNPs were added. No cytotoxicity of the HAuNPs was observed at the nanoparticle concentration up to 4.25×109 nanoparticles/ml (350 μM Au concentration). A small animal X-ray irradiator and a clinical linear accelerator were used to irradiate HAuNP-treated and control groups. It shows that the radiation damage to the cells is significantly enhanced when the cells are exposed to HAuNPs. This is the first time that AuNPs with diameter larger than 100 nm has been studied for their radiosensitizing effects. In clinical settings, we envision that HAuNPs could be intratumorally injected into tumors, which is more realistic for practical usage of AuNPs as radiosensitizer than passive accumulation in tumors using the enhanced permeability and retention effect or active targeting. Larger particles are favored for the intratumoral injection approach since larger particles tend to be retained in the injection sites, and are less likely to diffuse into surrounding normal tissues. So, this proof-of-concept evaluation shows a promising potential to use HAuNPs as radiation therapy sensitizer for cancers.

KW - Gold nanoparticles

KW - Hollow nanoparticles

KW - Radiation dose enhancement

KW - Radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=84929457960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929457960&partnerID=8YFLogxK

U2 - 10.4028/www.scientific.net/JNanoR.32.106

DO - 10.4028/www.scientific.net/JNanoR.32.106

M3 - Article

AN - SCOPUS:84929457960

VL - 32

SP - 106

EP - 112

JO - Journal of Nano Research

JF - Journal of Nano Research

SN - 1662-5250

ER -